生命科学资讯
生物技术与制药领域的最新动态
安捷伦科技公司$A股被荷兰国际集团减持 - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Assetmark Inc. 增持安捷伦科技公司股份 $A - MarketBeat
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
美国银行在安捷伦科技第二季度财报后维持持有评级 - MSN
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
安捷伦科技公司(NYSE:A)基本面表现强劲:市场是否对该股判断有误? - 雅虎财经
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
安捷伦科技公司A股股份遭朗姆线顾问公司减持 - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
FDA对卵巢癌的认可将焦点转向安捷伦估值与市场动能 - simplywall.st
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
安捷伦科技公司(NYSE:A)获分析师平均评级为“适度买入”——MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
安捷伦获FDA批准用于卵巢癌伴随诊断 - Femtech Insider
Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
安捷伦伴随诊断获FDA批准,与Keytruda最新癌症适应症同步获批。
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
安捷伦科技公司(NYSE:A)宣布派发每股0.26美元季度股息——MarketBeat报道
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent伴随诊断获FDA批准,与Keytruda最新癌症疗法同步获批——Fierce Biotech报道
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech
安捷伦宣布每股派发现金股息25.5美分 - 01net
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
安捷伦科技(A)宣布季度股息0.255美元,收益率0.8% - StreetInsider报道
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
安捷伦宣布每股派发现金股息25.5美分 - 商业资讯
Agilent Announces Cash Dividend of 25.5 Cents per Share - Business Wire
安捷伦宣布每股派发现金股息25.5美分 - 雅虎财经
Agilent Announces Cash Dividend of 25.5 Cents per Share - Yahoo Finance
持有安捷伦股票至3月31日?4月将获0.255美元现金分红——股票泰坦
Own Agilent stock by March 31? A $0.255 cash payout is coming in April - Stock Titan
安捷伦授予勃林格殷格翰首届2025仪器以旧换新影响力奖 - BioSpace
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - BioSpace
FDA批准推动安捷伦科技(A)诊断工具发展 - GuruFocus
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
安捷伦授予勃林格殷格翰首届2025仪器以旧换新影响力奖 - 商业资讯
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Business Wire